BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22929999)

  • 1. Development of a therapeutically important radiation induced promoter.
    Ogawa R; Morii A; Watanabe A; Cui ZG; Kagiya G; Fukuda S; Kume K; Hasegawa T; Hatashita M; Izumi H; Ishimoto T; Feril LB
    Bioengineered; 2013; 4(1):44-9. PubMed ID: 22929999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of gene expression in retrovirus vectors by X-ray and proton beam radiation with artificially constructed promoters.
    Ogawa R; Morii A; Watanabe A; Cui ZG; Kagiya G; Fukuda S; Kume K; Hasegawa T; Hatashita M; Izumi H; Ishimoto T; Feril LB
    J Gene Med; 2012 May; 14(5):316-27. PubMed ID: 22438286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of gene expression in prostate cancer cells with an artificially constructed promoter responsive to radiation.
    Morii A; Ogawa R; Watanabe A; Kakutani S; Zhao QL; Kume K; Kondo T; Fuse H
    Gene Ther; 2012 Feb; 19(2):219-27. PubMed ID: 21697955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of gene expression in human prostate cancer cells with artificially constructed promoters that are activated in response to ultrasound stimulation.
    Ogawa R; Morii A; Watanabe A; Cui ZG; Kagiya G; Kondo T; Doi N; Feril LB
    Ultrason Sonochem; 2013 Jan; 20(1):460-7. PubMed ID: 22695309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-tumor effect of suicide gene therapy using chimeric promoter plus radiotherapy on cancer cell lines].
    Sun WJ; Xiong J; Wang WF; Liao ZK; Zhou FX; Zhou YF
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):245-50. PubMed ID: 21575492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An artificially constructed radiation-responsive promoter is activated by doxorubicin.
    Ogawa R; Morii A; Watanabe A; Cui ZG; Kagiya G; Doi N; Zhao QL; Feril LB
    Cancer Gene Ther; 2012 May; 19(5):345-51. PubMed ID: 22402623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of X-ray-inducible promoters through cis-acting element elongation and error-prone polymerase chain reaction.
    Ogawa R; Lee SI; Kagiya G; Hirano H; Fukuda S; Kondo T; Kodaki T
    J Gene Med; 2008 Mar; 10(3):316-24. PubMed ID: 18161064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective enhancement of hypoxic cell killing by tempol-regulated suicide gene expression.
    Kagiya G; Ogawa R; Choudhuri R; Cook JA; Hatashita M; Tanaka Y; Koda K; Yamashita K; Kubo M; Kawakami F; Mitchell JB
    Oncol Rep; 2015 Aug; 34(2):1065-73. PubMed ID: 26034980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation.
    Kawashita Y; Ohtsuru A; Kaneda Y; Nagayama Y; Kawazoe Y; Eguchi S; Kuroda H; Fujioka H; Ito M; Kanematsu T; Yamashita S
    Hum Gene Ther; 1999 Jun; 10(9):1509-19. PubMed ID: 10395376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl methacrylate activates the Gsta1 promoter.
    Hattori N; Suzuki T; Jinno S; Okeya H; Ishikawa A; Kondo C; Hayashi T; Ito M; Kanamori T; Kawai T; Noguchi T
    J Dent Res; 2008 Dec; 87(12):1117-21. PubMed ID: 19029078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
    Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of microRNAs with decreased expression levels in response to X-ray irradiation for fine-tuning radiation-controlled gene regulation.
    Morii A; Ogawa R; Watanabe A; Cui ZG; Takasaki I; Doi N; Kondo T; Fuse H
    Int J Mol Med; 2013 Jul; 32(1):9-16. PubMed ID: 23612713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of artificial promoter activity by ultrasound-induced oxidative stress.
    Ogawa R; Lee SI; Izumi H; Kagiya G; Yohsida T; Watanabe A; Morii A; Kakutani S; Kondo T; Feril LB; Ishimoto T
    Ultrason Sonochem; 2009 Mar; 16(3):379-86. PubMed ID: 19041272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
    Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Renilla luciferase-Aequorea GFP (ruc-gfp) fusion gene construct permits real-time detection of promoter activation by exogenously administered mifepristone in vivo.
    Yu YA; Szalay AA
    Mol Genet Genomics; 2002 Oct; 268(2):169-78. PubMed ID: 12395191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing radiation-responsive gene promoters for radiogenetic cancer therapy.
    Scott SD; Joiner MC; Marples B
    Gene Ther; 2002 Oct; 9(20):1396-402. PubMed ID: 12365005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combining FCU/5-FU suicide gene/prodrug system and radiation in treating nasopharyngeal carcinoma: an experimental study].
    Tang YY; Zhao SP; Xu J; Zhong Y; Xiao JY
    Zhonghua Bing Li Xue Za Zhi; 2006 Aug; 35(8):483-7. PubMed ID: 17069702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study on lung carcinoma-targeted suicide gene therapy induced by irradiation].
    Wang WD; Chen ZT; Li DZ; Duan YZ; Cao ZH
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):84-7. PubMed ID: 12783658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of tissue- and cancer-selective promoters for the introduction of genes into human ovarian cancer cells.
    Tanyi JL; Lapushin R; Eder A; Auersperg N; Tabassam FH; Roth JA; Gu J; Fang B; Mills GB; Wolf J
    Gynecol Oncol; 2002 Jun; 85(3):451-8. PubMed ID: 12051873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the relative luciferase activity in secondary CEF by different heterogenous strong promoters, MDV gB promoter and the composed promoters].
    Qiu YF; Ge FF; Xu XQ; Chen PY
    Wei Sheng Wu Xue Bao; 2006 Apr; 46(2):314-7. PubMed ID: 16736599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.